| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anaemia in chronic kidney disease: what do new generation agents offer?
|
Tonelli, Marcello
|
|
|
399 |
10326 |
p. 702-703
|
artikel
|
| 2 |
A public health manifesto
|
Bagenal, Jessamy
|
|
|
399 |
10326 |
p. 710-711
|
artikel
|
| 3 |
Beyond anti-VEGF: can faricimab reduce treatment burden for retinal disease?
|
Chia, Mark A
|
|
|
399 |
10326 |
p. 697-699
|
artikel
|
| 4 |
Biden's science adviser resigns over bullying
|
Jaffe, Susan
|
|
|
399 |
10326 |
p. 705
|
artikel
|
| 5 |
COVID-19 in Europe: new challenges for addressing vaccine hesitancy
|
Karafillakis, Emilie
|
|
|
399 |
10326 |
p. 699-701
|
artikel
|
| 6 |
Department of Error
|
|
|
|
399 |
10326 |
p. e6
|
artikel
|
| 7 |
Diabetes and race in the USA over the past century
|
Tuchman, Arleen
|
|
|
399 |
10326 |
p. 712-713
|
artikel
|
| 8 |
Diagnostics for COVID-19: moving from pandemic response to control
|
Peeling, Rosanna W
|
|
|
399 |
10326 |
p. 757-768
|
artikel
|
| 9 |
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
|
Heier, Jeffrey S
|
|
|
399 |
10326 |
p. 729-740
|
artikel
|
| 10 |
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
|
Wykoff, Charles C
|
|
|
399 |
10326 |
p. 741-755
|
artikel
|
| 11 |
Hearing but not understanding: word deafness from a brainstem lesion
|
Pogson, Jacob M
|
|
|
399 |
10326 |
p. 756
|
artikel
|
| 12 |
Homozygous familiar hypercholesterolemia: still a long way to go
|
Sánchez-Hernández, Rosa M
|
|
|
399 |
10326 |
p. 696-697
|
artikel
|
| 13 |
Medical aid returns to Tigray
|
Devi, Sharmila
|
|
|
399 |
10326 |
p. 707
|
artikel
|
| 14 |
Offline: A lie at the heart of public health
|
Horton, Richard
|
|
|
399 |
10326 |
p. 704
|
artikel
|
| 15 |
Power and bullying in research
|
The Lancet,
|
|
|
399 |
10326 |
p. 695
|
artikel
|
| 16 |
Research Focus: the Arc Institute
|
Burki, Talha
|
|
|
399 |
10326 |
p. 708
|
artikel
|
| 17 |
Samuel K Roberts: illuminating history, racial bias, and public health
|
Prasad, Aarathi
|
|
|
399 |
10326 |
p. 709
|
artikel
|
| 18 |
Steroid use in non-pneumococcal and non-Haemophilus bacterial meningitis
|
Heining, Dominic
|
|
|
399 |
10326 |
p. 717-718
|
artikel
|
| 19 |
Steroid use in non-pneumococcal and non-Haemophilus bacterial meningitis – Authors' reply
|
van de Beek, Diederik
|
|
|
399 |
10326 |
p. 718
|
artikel
|
| 20 |
Three-dose vaccination elicits neutralising antibodies against omicron
|
Wu, Mary
|
|
|
399 |
10326 |
p. 715-717
|
artikel
|
| 21 |
UN sanctions hamper humanitarian work
|
Zarocostas, John
|
|
|
399 |
10326 |
p. 706
|
artikel
|
| 22 |
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
|
Tromp, Tycho R
|
|
|
399 |
10326 |
p. 719-728
|
artikel
|
| 23 |
Zena Stein
|
Green, Andrew
|
|
|
399 |
10326 |
p. 714
|
artikel
|
Tijdschrift beschrijving